- $5.43m
- $195.41m
- $294.95m
- 51
- 69
- 30
- 48
R2019 February 28th | R2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 312 | 322 | 309 | 296 | 295 |
Cost of Revenue | |||||
Gross Profit | 126 | 125 | 122 | 122 | 109 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 273 | 337 | 315 | 311 | 321 |
Operating Profit | 39 | -14.9 | -6.83 | -15.6 | -26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 26.8 | -30.6 | -20.6 | -30.1 | -31.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.5 | -51 | -21.2 | -31.1 | -32.5 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 18.4 | -79.3 | -56.3 | -28 | -32.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.4 | -79.3 | -56.3 | -28 | -32.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.84 | -26.8 | -11.7 | -18.1 | -16.1 |